Clinical Trial Update: Correlating Early FDG PET/CT and ctDNA in Immune Checkpoint Inhibitor (ICI)-Treated Melanoma Patients

View source ↗

Summary

This entry describes an ongoing University of Wisconsin–Madison clinical trial evaluating whether early FDG PET/CT imaging and circulating tumor DNA can predict…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Melanoma, Melanoma Stage III | Status: RECRUITING